Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder

J Pediatr Hematol Oncol. 2011 May;33(4):e156-9. doi: 10.1097/MPH.0b013e31820150d5.

Abstract

Primary cutaneous anaplastic large cell lymphoma with local lymph node involvement was diagnosed in a 13-year-old boy with an ulcerative facial lesion and a history of skin lesions of lymphomatoid papulosis. The tumor regressed with chemotherapy. He continued to develop recurrent self-limited lesions of lymphomatoid papulosis , with a halo surrounding these lesions during the healing phase. He developed selective immunoglobulin M deficiency with decline in levels even 4 years after the chemotherapy with no recurrent infections noted and adequate IgG response to immunizations. Both peripheral blood IgM+ and memory B cells were low, suggesting a possible cause-effect relationship between selective immunoglobulin M deficiency and chronic CD30+ cutaneous lymphoproliferative disorders.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Facial Neoplasms / drug therapy
  • Facial Neoplasms / immunology
  • Facial Neoplasms / pathology
  • Humans
  • Immunoglobulin M / deficiency*
  • Immunologic Memory / immunology
  • Ki-1 Antigen / metabolism*
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell / drug therapy
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell / immunology*
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell / pathology
  • Male
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / immunology
  • Neoplasm Recurrence, Local / pathology
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / immunology*
  • Skin Neoplasms / pathology

Substances

  • Immunoglobulin M
  • Ki-1 Antigen